Hutson Nancy J
- SEC CIK
- 0001379222
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncDirectoras of Jun 16, 2025
- CLSD Clearside Biomedical, Inc.Directoras of Jun 21, 2024
- PHAS PhaseBio Pharmaceuticals IncDirectoras of May 19, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hutson Nancy J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BCRX Biocryst Pharmaceuticals Inc
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 (view filing) | Dec 13 | 3 days | Hutson Nancy JDirector | SSale | −7.00K | $7.54 | −$52.8K | −7.5%86.6K after | 10b5-1 |
| May 22, 2024 (view filing) | May 20 | 2 days | Hutson Nancy JDirector | PPurchase | +5.00K | $6.38 | +$31.9K | +6.1%86.8K after | |
| Jun 15, 2023 (view filing) | Jun 14 | 1 day | Hutson Nancy JDirector | SSale | −12.9K | $8.04 | −$103.4K | −13.6%81.8K after | |
| Oct 19, 2021 (view filing) | Oct 15 | 4 days | Hutson Nancy JDirector | SSale | −105.0K | $15.40 | −$1.62M | −61.7%65.1K after |
CLSD Clearside Biomedical, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 4, 2023 (view filing) | Oct 3 | 1 day | Hutson Nancy JDirector | PPurchase | +10.0K | $0.86 | +$8.60K | +12.0%93.0K after | |
| Nov 21, 2022 (view filing) | Nov 17 | 4 days | Hutson Nancy JDirector | PPurchase | +30.0K | $1.33 | +$39.9K | +56.6%83.0K after | |
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Hutson Nancy JDirector | PPurchase | +3.00K | $5.68 | +$17.0K | +30.0%13.0K after |
PHAS PhaseBio Pharmaceuticals Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 (view filing) | Aug 18, 2021 | 275 days | Hutson Nancy JDirector | PPurchase | +3.00K | $3.08 | +$9.24K | +300.0%4.00K after | Amended |